Skip to main content

Table 4 Summary of the research question

From: Intensive follow-up for women with breast cancer: review of clinical, economic and patient’s preference domains through evidence to decision framework

Should women be followed intensively after breast cancer treatment?
Problem: Women treated for breast cancer are followed-up for monitoring treatment effectiveness and for detecting recurrences at an early stage, but the frequency of follow-up is under discussion. Background: Women treated for breast cancer are followed up for monitoring treatment effectiveness and for detecting recurrences at an early stage. Follow-up includes clinical and test examinations like routine haematological and liver function tests, tumour markers, chest X-ray, mammography, bone and liver scans. There is variability in the frequency of medical visits and the tests performed.
Option: Intensive follow-up.
Comparison: Non-intensive follow-up.
Main outcomes: 1. 10-year mortality due to breast cancer.
2. 5-year mortality due to breast cancer.
3. 5 (or 10)-year breast cancer specific survival.
4. 10-year breast cancer recurrences (loco-regional and distant separately).
5. 5-year breast cancer recurrences (logo-regional and distant separately).
6. Quality of life of breast cancer patients 2 (or 5) years after diagnosis.
7. Patient satisfaction with follow-up.
Setting: Breast cancer centres/other healthcare services.
Perspective: Population.
  1. Legend: this table represents the first part of the Evidence to Decision framework